These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32721125)

  • 1. Current clinical management of patients with glioblastoma.
    Lowe S; Bhat KP; Olar A
    Cancer Rep (Hoboken); 2019 Dec; 2(6):e1216. PubMed ID: 32721125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.
    Valdebenito S; D'Amico D; Eugenin E
    Cancer Rep (Hoboken); 2019 Dec; 2(6):e1220. PubMed ID: 32729241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of glioblastoma: State of the art and future directions.
    Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M
    CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.
    Li G; Zhai Y; Wang Z; Wang Z; Huang R; Jiang H; Li R; Feng Y; Chang Y; Jiang T; Zhang W
    Cancer Med; 2020 Mar; 9(6):1955-1965. PubMed ID: 31851783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
    Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.
    Zhao SG; Yu M; Spratt DE; Chang SL; Feng FY; Kim MM; Speers CW; Carlson BL; Mladek AC; Lawrence TS; Sarkaria JN; Wahl DR
    Neuro Oncol; 2019 Sep; 21(9):1141-1149. PubMed ID: 31121035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].
    Vauleon E; Mesbah H; Gedouin D; Lecouillard I; Louvel G; Hamlat A; Riffaud L; Carsin B; Quillien V; Audrain O; Lesimple T
    Bull Cancer; 2012 Feb; 99(2):121-6. PubMed ID: 22257744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for glioblastoma therapy associated complications.
    Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
    Clin Neurol Neurosurg; 2015 Jul; 134():55-9. PubMed ID: 25942630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment.
    Kong XT; Nguyen NT; Choi YJ; Zhang G; Nguyen HN; Filka E; Green S; Yong WH; Liau LM; Green RM; Kaprealian T; Pope WB; Nghiemphu PL; Cloughesy T; Lassman A; Lai A
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1195-1203. PubMed ID: 29722661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
    Wen J; Chen W; Zhu Y; Zhang P
    BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of newly diagnosed malignant glioma in the elderly people: new trials that impact therapy.
    Chamberlain MC
    Int J Clin Pract; 2013 Dec; 67(12):1225-7. PubMed ID: 24246204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of hypofractionated radiotherapy (HFRT) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: A meta-analysis.
    Guo L; Li X; Chen Y; Liu R; Ren C; Du S
    Cancer Radiother; 2021 Apr; 25(2):182-190. PubMed ID: 33436285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
    Parvez T
    Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results of glioblastoma during the last 30 years in a single institute.
    Kumabe T; Saito R; Kanamori M; Chonan M; Mano Y; Shibahara I; Kawaguchi T; Kato H; Yamashita Y; Sonoda Y; Kawagishi J; Jokura H; Watanabe M; Katakura R; Kayama T; Tominaga T
    Neurol Med Chir (Tokyo); 2013; 53(11):786-96. PubMed ID: 24140783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
    Butowski N; Chang SM; Lamborn KR; Polley MY; Pieper R; Costello JF; Vandenberg S; Parvataneni R; Nicole A; Sneed PK; Clarke J; Hsieh E; Costa BM; Reis RM; Hristova-Kazmierski M; Nicol SJ; Thornton DE; Prados MD
    Neuro Oncol; 2011 Dec; 13(12):1331-8. PubMed ID: 21896554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What next for newly diagnosed glioblastoma?
    Domingo-Musibay E; Galanis E
    Future Oncol; 2015; 11(24):3273-83. PubMed ID: 26558493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
    Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
    Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns.
    Comas S; Luguera E; Molero J; Balaña C; Estival A; Castañer S; Carrato C; Hostalot C; Teixidor P; Villà S
    Clin Transl Oncol; 2021 Mar; 23(3):554-564. PubMed ID: 32728970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.
    Ney DE; Carlson JA; Damek DM; Gaspar LE; Kavanagh BD; Kleinschmidt-DeMasters BK; Waziri AE; Lillehei KO; Reddy K; Chen C
    J Neurooncol; 2015 Mar; 122(1):135-43. PubMed ID: 25524817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.